ARKG
$43.17ARK Genomic Revolution ETF
Companies advancing genomics and molecular biology.
Expense ratio
0.75%
Dividend yield
0.00%
AUM
$1.73B
Issuer
ARK
YTD return
44.53%
1Y return
—
5Y return
—
10Y return
—
Top holdings
Top holdings · ARKG
| TWST | Twist Bioscience Corp | 9.15% |
| TEM | Tempus AI Inc Class A common stock | 7.64% |
| ABSI | Absci Corp | 7.01% |
| TXG | 10x Genomics Inc Ordinary Shares - Class A | 7.00% |
| CRSP | CRISPR Therapeutics AG | 6.56% |
| PSNL | Personalis Inc | 6.19% |
| BEAM | Beam Therapeutics Inc | 4.34% |
| GH | Guardant Health Inc | 4.28% |
| NTRA | Natera Inc | 4.11% |
| ILMN | Illumina Inc | 3.98% |
Sector exposure
Sector breakdown · ARKG
Healthcare100.0%